Clincosm LogoSign in Get a demo

Hematologic Malignancy

Showing 1 - 25 of 166
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Boston (PATH-C)

Not yet recruiting
  • Hematologic Malignancy
  • PATH-C
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Nov 23, 2023

Venetoclax Tablets Crushed and Dissolved Into a Solution

Not yet recruiting
  • Hematologic Malignancy
  • +18 more
  • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Nov 8, 2023

BTK Inhibitors-related AF Treated by Catheter Ablation

Not yet recruiting
  • BTKi-induced Atrial Fibrillation
  • +2 more
  • Atrial fibrillation catheter ablation in a population of BTKi-induced atrial fibrillation
  • Caen, Normandy, France
    Caen University Hospital
Nov 10, 2023

Immune Profiling for Cancer Immunotherapy Response

Recruiting
  • Cancer
  • +3 more
  • Methylation Cytometry
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Nov 6, 2023

Hematologic Malignancy Trial (Cyclophosphamid, ATG)

Not yet recruiting
  • Hematologic Malignancy
  • (no location specified)
Oct 29, 2023

Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))

Recruiting
  • Hematologic Malignancy
  • B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
  • Duarte, California
    City of Hope
Oct 20, 2023

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Hematologic Malignancy Trial in Tianjin (BR108 injection)

Recruiting
  • Hematologic Malignancy
  • BR108 injection
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 25, 2023

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

Not yet recruiting
  • Graft Vs Host Disease
  • +5 more
  • CliniMACS® device
  • (no location specified)
Jul 20, 2023

Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))

Recruiting
  • Hematologic Malignancy
  • CD45RA depleted donor lymphocyte infusion (DLI)
  • Tuebingen,, Germany
  • +1 more
Jul 13, 2023

Hematologic Malignancy, Stem Cell Transplant Complications Trial in Beijing (Beijing protocol)

Recruiting
  • Hematologic Malignancy
  • Stem Cell Transplant Complications
  • Beijing protocol
  • Beijing, Beijing, China
    Deparment of Hematology, Peking University People's Hospital
Jun 19, 2023

(Proteomic and Genomic Analysis of Biospecimens)

Enrolling by invitation
  • Oncology
  • +8 more
  • Observational Study Only. NO Intervention.
  • New Orleans, Louisiana
    AUD
Jun 2, 2023

Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

Not yet recruiting
  • Hematologic Malignancy
  • +5 more
  • autologous hematopoietic stem cells added to planned CAR T
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 31, 2023

Prospective Validation of the OHI Index

Recruiting
  • HLH
  • +4 more
    • Kfar Saba, Israel
    • +1 more
    May 21, 2023

    Hematologic Malignancy Trial in Tianjin (IMM01)

    Terminated
    • Hematologic Malignancy
    • Tianjin, Tianjin, China
      Chinese Academy of Medical Sciences and Peking Union Medical Col
    May 5, 2023

    Hematologic Malignancy Trial in Bologna

    Recruiting
    • Hematologic Malignancy
      • Bologna, Italy
        Programma Dipartimentale Terapie Cellulari Avanzate
      Apr 17, 2023

      Hematologic Malignancy, Hematologic Tumors, Hematologic Diseases Trial in Nanjing, Suzhou, Tianjin (Flow Cytometry)

      Not yet recruiting
      • Hematologic Malignancy
      • +2 more
      • Flow Cytometry
      • Nanjing, Jiangsu, China
      • +2 more
      Apr 17, 2023

      Hematologic Malignancy Trial (Cold-stored platelet concentrate)

      Not yet recruiting
      • Hematologic Malignancy
      • Cold-stored platelet concentrate
      • (no location specified)
      Apr 14, 2023

      Immunity to Infection in Healthy Participants and Cancer

      Recruiting
      • Influenza
      • +3 more
      • Biological sample collection
      • Tuebingen, Baden-Wuerttemberg, Germany
        University Hopsital Tuebingen
      Mar 31, 2023

      Hematologic Malignancy, Lymphoma Trial (Home-based training, Center-based training)

      Not yet recruiting
      • Hematologic Malignancy
      • Lymphoma
      • Home-based training
      • Center-based training
      • (no location specified)
      Mar 20, 2023

      Oral Complications in Hematological Malignancies

      Not yet recruiting
      • Hematologic Malignancy
        • Assiut, Egypt
          Assiut university
        Mar 6, 2023

        Hematological Malignancies - SANGUINE

        Recruiting
        • Hematologic Malignancy
        • Blood sampling for HemaChip screening/diagnostic testing
        • Bone marrow sampling
        • Olomouc, Czechia
        • +3 more
        Feb 9, 2023

        Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

        Not yet recruiting
        • Hematologic Malignancy
        • +21 more
        • (no location specified)
        Feb 9, 2023

        Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)

        Not yet recruiting
        • Hematologic Malignancy
        • +2 more
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Feb 6, 2023